Low voltage criteria EKG as a harbinger of systemic disease

AL amyloidosis is due to deposition of protein derived from immunoglobulin light chain fragments. It is a systemic disorder in which deposition of plasma proteins can adversely affect function of the heart, liver, kidneys, and peripheral nerves. Deposition in the heart results in a decrease in the a...

Full description

Bibliographic Details
Main Authors: Ian Garrahy, Daniel Forman, Sharon Swierczynski
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2019-05-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Online Access:http://dx.doi.org/10.1080/20009666.2019.1620092
_version_ 1797973007476457472
author Ian Garrahy
Daniel Forman
Sharon Swierczynski
author_facet Ian Garrahy
Daniel Forman
Sharon Swierczynski
author_sort Ian Garrahy
collection DOAJ
description AL amyloidosis is due to deposition of protein derived from immunoglobulin light chain fragments. It is a systemic disorder in which deposition of plasma proteins can adversely affect function of the heart, liver, kidneys, and peripheral nerves. Deposition in the heart results in a decrease in the amplitude of the electrical activity of the heart and can be an early clue to the diagnosis. A 63-year-old male admitted for volume overload was found to have nephrotic range proteinuria, progressive renal insufficiency (Creatinine 4.0 increased from his baseline 0.9), and hypoalbuminemia. On exam, he had diffuse anasarca and peripheral neuropathy. A renal biopsy showed AL amyloidosis, lambda related, involving the glomeruli, interstitium, and arterial walls. Bone marrow biopsy showed 30% plasma cells with lambda light chain predominance. Serum free light chains were elevated. Lamda was 11.50 mg/dL and kappa was 5.12 mg/dL. In retrospective review of his chart, an EKG with low voltage and anterior pseudo-infarct pattern was first apparent on an admission for stroke two years prior. Echocardiogram showed mild concentric left ventricular hypertrophy. The patient was started on chemotherapy with Bortezomib. The differential of a low-voltage EKG includes many common pulmonary and chest wall (COPD, obesity) as well as pericardial diseases (effusions), but also important rarer infiltrative diseases including sarcoidosis and amyloidosis. Amyloidosis of the heart can cause progressive irreversible heart failure, but its progress can be altered if identified early. Physicians should consider amyloidosis when faced with a low-voltage EKG along with systemic symptoms including nephrotic range proteinuria, peripheral neuropathy, hepatosplenomegaly, and macroglossia.
first_indexed 2024-04-11T03:57:36Z
format Article
id doaj.art-9d54816076db4f61a6e55b3ae0fb21b8
institution Directory Open Access Journal
issn 2000-9666
language English
last_indexed 2024-04-11T03:57:36Z
publishDate 2019-05-01
publisher Greater Baltimore Medical Center
record_format Article
series Journal of Community Hospital Internal Medicine Perspectives
spelling doaj.art-9d54816076db4f61a6e55b3ae0fb21b82023-01-02T00:15:24ZengGreater Baltimore Medical CenterJournal of Community Hospital Internal Medicine Perspectives2000-96662019-05-019322622910.1080/20009666.2019.16200921620092Low voltage criteria EKG as a harbinger of systemic diseaseIan Garrahy0Daniel Forman1Sharon Swierczynski2Reading HospitalReading HospitalReading HospitalAL amyloidosis is due to deposition of protein derived from immunoglobulin light chain fragments. It is a systemic disorder in which deposition of plasma proteins can adversely affect function of the heart, liver, kidneys, and peripheral nerves. Deposition in the heart results in a decrease in the amplitude of the electrical activity of the heart and can be an early clue to the diagnosis. A 63-year-old male admitted for volume overload was found to have nephrotic range proteinuria, progressive renal insufficiency (Creatinine 4.0 increased from his baseline 0.9), and hypoalbuminemia. On exam, he had diffuse anasarca and peripheral neuropathy. A renal biopsy showed AL amyloidosis, lambda related, involving the glomeruli, interstitium, and arterial walls. Bone marrow biopsy showed 30% plasma cells with lambda light chain predominance. Serum free light chains were elevated. Lamda was 11.50 mg/dL and kappa was 5.12 mg/dL. In retrospective review of his chart, an EKG with low voltage and anterior pseudo-infarct pattern was first apparent on an admission for stroke two years prior. Echocardiogram showed mild concentric left ventricular hypertrophy. The patient was started on chemotherapy with Bortezomib. The differential of a low-voltage EKG includes many common pulmonary and chest wall (COPD, obesity) as well as pericardial diseases (effusions), but also important rarer infiltrative diseases including sarcoidosis and amyloidosis. Amyloidosis of the heart can cause progressive irreversible heart failure, but its progress can be altered if identified early. Physicians should consider amyloidosis when faced with a low-voltage EKG along with systemic symptoms including nephrotic range proteinuria, peripheral neuropathy, hepatosplenomegaly, and macroglossia.http://dx.doi.org/10.1080/20009666.2019.1620092Cardiac amyloidosiselectrocardiography
spellingShingle Ian Garrahy
Daniel Forman
Sharon Swierczynski
Low voltage criteria EKG as a harbinger of systemic disease
Journal of Community Hospital Internal Medicine Perspectives
Cardiac amyloidosis
electrocardiography
title Low voltage criteria EKG as a harbinger of systemic disease
title_full Low voltage criteria EKG as a harbinger of systemic disease
title_fullStr Low voltage criteria EKG as a harbinger of systemic disease
title_full_unstemmed Low voltage criteria EKG as a harbinger of systemic disease
title_short Low voltage criteria EKG as a harbinger of systemic disease
title_sort low voltage criteria ekg as a harbinger of systemic disease
topic Cardiac amyloidosis
electrocardiography
url http://dx.doi.org/10.1080/20009666.2019.1620092
work_keys_str_mv AT iangarrahy lowvoltagecriteriaekgasaharbingerofsystemicdisease
AT danielforman lowvoltagecriteriaekgasaharbingerofsystemicdisease
AT sharonswierczynski lowvoltagecriteriaekgasaharbingerofsystemicdisease